Explore the groundbreaking CAR T cell therapy for lymphoma in this informative talk by UCLA hematologist Dr. Sarah Larson. Delve into the latest research aimed at enhancing the safety and efficacy of this promising therapeutic approach. Gain insights into CAR T targets, antigen escape, stem cells, and safety considerations. Learn about the Leukemia Lymphoma Society and the Climb to Cure initiative. Discover how engineered cell therapy is advancing cancer treatment at UCLA and participate in a Q&A session to deepen your understanding of this cutting-edge medical breakthrough.
CAR T at UCLA - Driving the Progress of Engineered Cell Therapy
University of California, Los Angeles via YouTube
Overview
Syllabus
Introduction
Research Goals
CAR T Targets
Antigen Escape
Stem Cells
Safety
Conclusion
Leukemia Lymphoma Society
Climb to Cure
Questions
Taught by
UCLA Health
Tags
Related Courses
-
Novel Therapies for Multiple Myeloma - Closer to a Cure Community Lecture Series
-
Understanding the Mechanisms of Resistance in CAR T Immunotherapy for Lymphoma and Strategies to Overcome Them
-
Engineering Enhanced Chimeric Antigen Receptor T-Cell Therapy
-
Advancements in the Treatment of Blood Cancers - Closer to a Cure Series
4.0 -
CAR T-Cell Therapy and Scleroderma - Today and Future - 2024
-
CAR T-Cell Therapy for Pediatric Cancer - Satiro de Oliveira, MD - UCLAMDChat
